Oncotelic Therapeutics, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Oncotelic Therapeutics, Inc. (OTLC) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $6.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-30.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2015-03-30
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-12-31 was $1.00K, a 66.67% decline year-over-year.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-06-30 was $4.00K.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2012-03-31 was $1.00K, a 99.95% decline year-over-year.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2012 was $6.00K, a 99.73% decline from fiscal 2011.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2011 was $2.22M.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2010 was -$6.02M, a 377.84% decline from fiscal 2009.
- Oncotelic Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2009 was $2.17M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $1.00K derived: sum of 2 quarters · filed 2015-03-30 | $5.00K derived: sum of 3 quarters · filed 2015-03-30 | $6.00K 10-K · filed 2015-03-30 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-13 | $4.00K derived: sum of 2 quarters · filed 2013-11-13 | $5.00K 10-Q · filed 2013-11-13 | $8.00K derived: sum of 4 quarters · filed 2014-03-20 |
| 2012-06-30 | $4.00K 10-Q/A · filed 2013-10-18 | $5.00K 10-Q/A · filed 2013-10-18 | $8.00K derived: sum of 3 quarters · filed 2014-03-20 | $48.00K derived: sum of 4 quarters · filed 2014-03-20 |
| 2012-03-31 | $1.00K 10-Q · filed 2013-05-09 | $4.00K derived: sum of 2 quarters · filed 2014-03-20 | $44.00K derived: sum of 3 quarters · filed 2014-03-20 | $13.00K derived: sum of 4 quarters · filed 2014-03-20 |
| 2011-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $43.00K derived: sum of 2 quarters · filed 2014-03-20 | $12.00K derived: sum of 3 quarters · filed 2014-03-20 | $2.22M 10-K · filed 2014-03-20 |
| 2011-09-30 | $40.00K 10-Q · filed 2012-11-09 | $9.00K derived: sum of 2 quarters · filed 2012-11-09 | $2.22M 10-Q · filed 2012-11-09 | $3.19M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$31.00K 10-Q · filed 2012-08-13 | $2.18M 10-Q · filed 2012-08-13 | $3.15M derived: sum of 3 quarters · filed 2013-03-15 | -$6.75M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $2.21M 10-Q · filed 2012-05-11 | $3.18M derived: sum of 2 quarters · filed 2013-03-15 | -$6.71M derived: sum of 3 quarters · filed 2013-03-15 | $825.00K derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $969.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$8.92M derived: sum of 2 quarters · filed 2013-03-15 | -$1.39M derived: sum of 3 quarters · filed 2013-03-15 | -$6.02M 10-K · filed 2013-03-15 |
| 2010-09-30 | -$9.89M 10-Q · filed 2011-11-10 | -$2.35M derived: sum of 2 quarters · filed 2011-11-10 | -$6.99M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $7.54M 10-Q · filed 2011-08-12 | $2.91M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $2.17M 10-K · filed 2012-03-28 |